These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33289812)

  • 1. Neurodegenerative Dementias Are Differentiated on PET Scans.
    Abbasi J
    JAMA; 2020 Dec; 324(22):2247. PubMed ID: 33289812
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular neuroimaging in degenerative dementias.
    Jiménez Bonilla JF; Carril Carril JM
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):301-9. PubMed ID: 23933381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.
    Del Sole A; Malaspina S; Magenta Biasina A
    Funct Neurol; 2016; 31(4):205-215. PubMed ID: 28072381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.
    Wren MC; Lashley T; Årstad E; Sander K
    Acta Neuropathol Commun; 2018 May; 6(1):34. PubMed ID: 29716656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
    Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
    Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography of the brain in degenerative dementias: clinical applications and development of new tracers.
    Santens P
    Acta Neurol Belg; 2002 Jun; 102(2):74-5. PubMed ID: 12161903
    [No Abstract]   [Full Text] [Related]  

  • 8. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.
    Silverman DH
    J Nucl Med; 2004 Apr; 45(4):594-607. PubMed ID: 15073255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain PET in suspected dementia: patterns of altered FDG metabolism.
    Brown RK; Bohnen NI; Wong KK; Minoshima S; Frey KA
    Radiographics; 2014; 34(3):684-701. PubMed ID: 24819789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
    Wenzel F; Young S; Wilke F; Apostolova I; Arlt S; Jahn H; Thiele F; Buchert R
    Neuroimage; 2010 Apr; 50(3):994-1003. PubMed ID: 20053378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography.
    Wang YT; Edison P
    Curr Neurol Neurosci Rep; 2019 Jun; 19(7):45. PubMed ID: 31172290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures.
    Grassetto G; Marzola MC; Musto A; Viniamury S; Colletti PM; Perkins AC; Rubello D
    Nucl Med Commun; 2014 Nov; 35(11):1085-92. PubMed ID: 25162962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of Biomarker Data in Diagnosis of Primary Dementias.
    Salardini A
    Semin Neurol; 2019 Apr; 39(2):200-212. PubMed ID: 30925613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance for reading FDG PET scans in dementia patients.
    Herholz K
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):332-43. PubMed ID: 25391316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on PET in neurodegenerative and neuroinflammatory disorders manifesting on a behavioural level: imaging for differential diagnosis.
    Hellwig S; Domschke K; Meyer PT
    Curr Opin Neurol; 2019 Aug; 32(4):548-556. PubMed ID: 31107281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau imaging with PET: an overview of challenges, current progress, and future applications.
    Robertson JS; Rowe CC; Villemagne VL
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):405-413. PubMed ID: 28750496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation technique and improvements introduced in a new dedicated brain positron emission tomograph (CareMiBrain).
    Cabrera-Martín MN; González-Pavón G; Sanchís Hernández M; Morera-Ballester C; Matías-Guiu JA; Carreras Delgado JL
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(4):239-248. PubMed ID: 34218886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New advances in tau imaging in parkinsonism.
    Valli M; Strafella AP
    Int Rev Psychiatry; 2017 Dec; 29(6):628-635. PubMed ID: 29206491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voyage au bout de la nuit: Aβ and tau imaging in dementias.
    Zwan MD; Okamura N; Fodero-Tavoletti MT; Furumoto S; Masters CL; Rowe CC; Villemagne VL
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):398-412. PubMed ID: 25358680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target-specific PET probes for neurodegenerative disorders related to dementia.
    Kadir A; Nordberg A
    J Nucl Med; 2010 Sep; 51(9):1418-30. PubMed ID: 20810758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.